Cargando…

Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus

OBJECTIVE: Adenosine deaminase (ADA) plays an important role in cell-mediated immunity and modulation of insulin activity. Its clinical and diagnostic significance in Nepalese type 2 diabetes is not yet characterized. So, this study's objective was to determine the isoenzymatic activities of AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sapkota, Lokendra Bahadur, Thapa, Sangita, Subedi, Nuwadatta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353251/ https://www.ncbi.nlm.nih.gov/pubmed/28321313 http://dx.doi.org/10.1136/bmjdrc-2016-000357

Ejemplares similares

The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2022)

Bacteriological assessment of stethoscopes used by healthcare workers in a tertiary care centre of Nepal
por: Thapa, Sangita, et al.
Publicado: (2017)

Changing Trend of Neonatal Septicemia and Antibiotic Susceptibility Pattern of Isolates in Nepal
por: Thapa, Sangita, et al.
Publicado: (2019)

Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?
por: Niraula, A., et al.
Publicado: (2018)

Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus
por: Larijani, Bagher, et al.
Publicado: (2016)

Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
por: Gao, Zhao-wei, et al.
Publicado: (2022)

Raised Serum Adenosine Deaminase Level in Nonobese Type 2 Diabetes Mellitus
por: Khemka, Vineet Kumar, et al.
Publicado: (2013)

Clinical profile of diabetes mellitus in tuberculosis
por: Ogbera, Anthonia Okeoghene, et al.
Publicado: (2015)

The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)
por: Kelly, Katherine, et al.
Publicado: (2016)

Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-α (TNFα) concentration in chronic heart failure
por: Khodadadi, IrajI, et al.
Publicado: (2014)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

A Rare Case of Adenosine Deaminase tRNA-Specific 3 Mutation, Adrenal Insufficiency, and Rhabdomyolysis
por: AlDhalaan, Waheeb, et al.
Publicado: (2021)

Burden of scrub typhus among patients with acute febrile illness attending tertiary care hospital in Chitwan, Nepal
por: Thapa, Sangita, et al.
Publicado: (2020)

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials
por: Davidson, Jaime A, et al.
Publicado: (2014)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2008)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

Characterization of total adenosine deaminase activity (ADA) and its isoenzymes in saliva and serum in health and inflammatory conditions in four different species: an analytical and clinical validation pilot study
por: Contreras-Aguilar, María Dolores, et al.
Publicado: (2020)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus
por: Mannar, Velmurugan, et al.
Publicado: (2023)

Genetics of Type 1 Diabetes: What's Next?
por: Pociot, Flemming, et al.
Publicado: (2010)

Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle Modification
por: Li, Matthias, et al.
Publicado: (2023)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
por: Zhulai, Galina, et al.
Publicado: (2022)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Air Pollution and Type 2 Diabetes: Mechanistic Insights
por: Rajagopalan, Sanjay, et al.
Publicado: (2012)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Adenosine deaminase activity in leukaemia.
por: Smyth, J. F., et al.
Publicado: (1975)

Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma-associated epilepsy
por: HUANG, JUN, et al.
Publicado: (2015)

G22A Polymorphism of Adenosine Deaminase and its Association with Biochemical Characteristics of Gestational Diabetes Mellitus in an Iranian Population
por: Takhshid, Mohammad Ali, et al.
Publicado: (2015)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

A Global Overview of Precision Medicine in Type 2 Diabetes
por: Fitipaldi, Hugo, et al.
Publicado: (2018)

The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes
por: Purcell, Anthony W., et al.
Publicado: (2019)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase– lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
por: Kumar, Rahat, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fn6tktav27j471tu77l59vu0u0